mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |